Relievant Seeks FDA Clearance Of AF Ablation For Back Pain
This article was originally published in The Gray Sheet
Executive Summary
Relievant Medsystems plans to start a multi-center clinical trial later this year to support FDA clearance of its Intracept radiofrequency ablation system to treat back pain